IMMUNIC, INC. (IMUX) Deferred Tax Assets, Valuation Allowance USD 2013 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Immunic, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2013 to 2023.
Immunic, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $99.1M, a 35.6% increase year-over-year.

Deferred Tax Assets, Valuation Allowance, Quarterly Data (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$99.1M	+$26M	+35.6%	Dec 31, 2023	10-K	2024-02-22
Q4 2022	$73.1M	+$14.2M	+24.2%	Dec 31, 2022	10-K	2024-02-22
Q4 2021	$58.8M	+$22.3M	+61.1%	Dec 31, 2021	10-K	2023-02-23
Q4 2020	$36.5M	+$8.16M	+28.8%	Dec 31, 2020	10-K	2022-02-24
Q4 2019	$28.4M	+$22.3M	+371%	Dec 31, 2019	10-K	2021-02-26
Q4 2018	$6.02M	-$77.8M	-92.8%	Dec 31, 2018	10-K	2020-03-16
Q4 2017	$83.9M	+$14.2M	+20.5%	Dec 31, 2017	10-K	2019-03-04
Q4 2016	$69.6M	+$7.33M	+11.8%	Dec 31, 2016	10-K	2018-03-13
Q4 2015	$62.3M	+$22.5M	+56.6%	Dec 31, 2015	10-K	2017-03-07
Q4 2014	$39.8M	+$21.5M	+118%	Dec 31, 2014	10-K	2016-03-08
Q4 2013	$18.3M			Dec 31, 2013	10-K	2015-03-20

* An asterisk sign (*) next to the value indicates that the value is likely invalid.